mRNA Stem-Loop Screening for RNA-Binding Drug Discovery

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Existing methods for drug discovery targeting RNA as a therapeutic target are limited by the lack of diversity in druggable sites and inefficient secondary structure prediction, particularly for mRNA, which hinders the identification of low-molecular-weight compounds that can modulate gene expression.

Innovation Solution

A method involving the use of multiple RNA conformation analysis programs to identify stem-loop structures in mRNA sequences, followed by the design of RNA probes to screen for low-molecular-weight compounds that stabilize these structures and regulate mRNA translation, using FRET probes to measure stability changes.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If conventional small molecule drugs target proteins, then drug discovery is well-established, but RNA is not considered a promising target due to lack of stable three-dimensional structures and druggable sites

Engineering Contradiction:

Improvedruggability of RNAVSAvoidstability of RNA three-dimensional structure

Core Design Contradiction:

Adaptability or versatilityVSReliability

Solution Approach 1:

The patent performs preliminary computational analysis to identify RNA secondary structures with characteristics suitable for small molecule binding before actual drug discovery. By pre-selecting RNA targets with predicted stable local structures, the method prepares the groundwork for successful compound screening, resolving the contradiction between RNA's general structural instability and the need for stable druggable sites.

Inventive Principle:

Principle #10Preliminary action

2Adaptability or versatility

If exhaustive search of all mRNA secondary structures is performed, then coverage of druggable targets is improved, but computational time and resources increase significantly

Engineering Contradiction:

Improvecoverage of druggable RNA targetsVSAvoidcomputational time for structure prediction

Core Design Contradiction:

Adaptability or versatilityVSLoss of time

Solution Approach 1:

Instead of analyzing entire mRNA sequences globally, the patent focuses computational resources on identifying and analyzing local secondary structure elements (such as stem-loops and hairpins) that are most likely to be druggable. This local approach maintains comprehensive coverage of potential targets while significantly reducing computational burden by avoiding exhaustive analysis of non-druggable regions.

Inventive Principle:

Principle #3Local quality

Solution Approach 2:

The patent divides the mRNA sequence into smaller functional segments or structural elements (secondary structures) and analyzes each segment independently for druggability characteristics. This segmentation allows parallel processing of multiple structures, improving both coverage and computational efficiency by avoiding the need to evaluate entire long sequences as single units.

Inventive Principle:

Principle #1Segmentation

3Adaptability or versatility

If limited microRNAs are used as drug discovery targets, then riboswitch structures can be targeted, but the diversity of druggable targets remains insufficient

Engineering Contradiction:

Improvediversity of mRNA targetsVSAvoidcomplexity of target identification system

Core Design Contradiction:

Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent develops a universal computational framework that can identify druggable secondary structures across all mRNA types, not just limited to specific microRNAs or riboswitches. This multi-functional approach allows the same methodology to be applied to diverse RNA targets including coding mRNAs, non-coding RNAs, and various structural elements, greatly expanding target diversity without proportionally increasing system complexity.

Inventive Principle:

Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables the precise identification and stabilization of mRNA substructures, allowing for the development of low-molecular-weight compounds that effectively modulate gene expression and treat diseases by regulating protein synthesis.

Implementation Method 1

using FRET probes to measure stability changes

Methodology Applied

Scientific EffectFRET (Fluorescence Resonance Energy Transfer):

Data Source

PatentUS20250361546A1Screening methods for RNA-controlling compounds

Publication Date: 2025.11.27 VERITAS IN SILICO INC

AI summary

A method for screening a compound capable of regulating gene expression by binding to a transcription product particularly for obtaining a drug candidate compound. The method includes selecting a stem-loop structure as a desired motif in an RNA, inputting a parameter of a specific stem-loop structure, and executing a plurality of RNA higher-order structural analysis programs to search/extract a sequence that can assume the structure in a molecule thereof from an mRNA sequence, selecting a specific target sequence in a specific transcription product as an indicator of the position at which the stem-loop structure is present in the molecule in an mRNA having significance for development of a potential drug target in an object disease or the like from the extracted mRNA, designing/preparing a labeling probe on the basis of the sequence, performing screening using the labeling probe as an assessment system, and acquiring a low-molecular-weight compound that selectively stabilizes the stem-loop structure.